Combination of serum albumin and cholinesterase levels as prognostic indicator in patients ith colorectal cancer

Manabu Yamamoto, Hiroaki Saito, Chihiro Uejima, Akimitsu Tanio, Yoichiro Tada, Tomoyuki Matsunaga, Teruhisa Sakamoto, Soichiro Honjo, Keigo Ashida, Yoshiyuki Fujiwara

Research output: Contribution to journalArticlepeer-review

23 Citations (Scopus)


Background/Aim: Nutritional status is strongly associated with cancer prognosis. The aim of this study was to identify the most useful combination of nutrition-related serum markers for predicting prognosis of patients with colorectal cancer (CRC). Patients and Methods: A total of 523 patients who underwent proctocolectomies for CRC at our hospital were enrolled in this study. Serum concentrations of albumin, cholinesterase and total cholesterol, and total peripheral lymphocyte count (TLC) were used as nutrition-related markers. Results: In multivariate analysis of nutrition-related markers, serum albumin and cholinesterase levels were found to be independent prognostic indicators. Cut-off values from receiver operating characteristic analyses were used to sort patients as ChE High or ChE Low (serum cholinesterase level ≥ or <221.5), and as Alb High or Alb Low (serum albumin level ≥ or <3.85). We then sorted them into three groups: ChE High /Alb High (Group A); ChE High /Alb Low or ChE Low /Alb High (Group B); and ChE Low /Alb Low (Group C). Their 5-year overall survival rates differed significantly (Group A: 81.6%, Group B: 62.1%, Group C: 42.7%, p<0.0001); as did their 5-year disease-specific survival rates (Group A: 90.1%, Group B: 73.8%, Group C: 62.2%, p<0.0001). Conclusion: The combination of serum cholinesterase and albumin levels is useful for predicting the prognosis of patients with CRC.

Original languageEnglish
Pages (from-to)1085-1090
Number of pages6
JournalAnticancer research
Issue number2
Publication statusPublished - 02-2019

All Science Journal Classification (ASJC) codes

  • Oncology
  • Cancer Research


Dive into the research topics of 'Combination of serum albumin and cholinesterase levels as prognostic indicator in patients ith colorectal cancer'. Together they form a unique fingerprint.

Cite this